Cell expression system
AssigneeNeuClone Biologics Pty Ltd
InventorNoelle Sunstrom
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeuClone Biologics Pty Ltd
InventorNoelle Sunstrom
Estimating the term…
An expression system for expressing a protein comprising: a eukaryotic host cell carrying a dihydrofolate reductase (DHFR) deficiency; and an expression vector, the expression vector encoding the human growth hormone gene; a expression vector, the expression vector comprising: a eukaryotic selectable marker including a minimal SV 40 early promoter driving expression of a sequence encoding dihydrofolate reductase for complementing the DHFR deficiency in the host cell; a prokaryotic selectable marker conveying Ampicillin resistance to a prokaryotic host cell; a prokaryotic Origin of Replication; a plurality of multiple cloning sites (MCS); and at least one protein expression module comprising: a Simian Vacuolating Virus 40 (SV40) early promoter, inclusive of its 72 bp enhancer repeats; and a rabbit β-globin intron sequence being separable from a SV40 p A sequence by a first multiple cloning site, for receiving a coding sequence and expressing a desired protein therefrom.
A method for producing a desired recombinant polypeptide comprising culturing a mammalian host cell expressing a desired recombinant polypeptide in a cell culture media comprising a human Growth Hormone (hGH) or modified hGH, wherein the hGH or modified hGH is added to the cell culture media and enhances survival and/or cell density and/or cell viability of the mammalian host cell expressing the desired recombinant polypeptide.
Dependencies are inferred from the claim text.